| Literature DB >> 35640610 |
Tyler A Rice1, Agata A Bielecka1, Mytien T Nguyen1, Connor E Rosen1, Deguang Song1, Nicole D Sonnert1, Yi Yang1, Yiyun Cao1, Varnica Khetrapal1, Jason R Catanzaro2, Anjelica L Martin1, Saleh A Rashed1, Shana R Leopold1, Liming Hao3, Xuezhu Yu4, David van Dijk4, Aaron M Ring1, Richard A Flavell1, Marcel R de Zoete5, Noah W Palm6.
Abstract
The impacts of individual commensal microbes on immunity and disease can differ dramatically depending on the surrounding microbial context; however, the specific bacterial combinations that dictate divergent immunological outcomes remain largely undefined. Here, we characterize an immunostimulatory Allobaculum species from an inflammatory bowel disease patient that exacerbates colitis in gnotobiotic mice. Allobaculum inversely associates with the taxonomically divergent immunostimulatory species Akkermansia muciniphila in human-microbiota-associated mice and human cohorts. Co-colonization with A. muciniphila ameliorates Allobaculum-induced intestinal epithelial cell activation and colitis in mice, whereas Allobaculum blunts the A.muciniphila-specific systemic antibody response and reprograms the immunological milieu in mesenteric lymph nodes by blocking A.muciniphila-induced dendritic cell activation and T cell expansion. These studies thus identify a pairwise reciprocal interaction between human gut bacteria that dictates divergent immunological outcomes. Furthermore, they establish a generalizable framework to define the contextual cues contributing to the "incomplete penetrance" of microbial impacts on human disease.Entities:
Keywords: IgA; IgA-Seq; gut microbiota; human gut bacteria; human microbiota-associated gnotobiotic mice; immunoglobulin A; immunostimulatory commensals; inflammatory bowel disease; mucosal immunity; reciprocal epistasis
Mesh:
Year: 2022 PMID: 35640610 PMCID: PMC9283318 DOI: 10.1016/j.chom.2022.05.004
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 31.316